High glucose concentration impairs ATP outflow and immunoglobulin production by human peripheral B lymphocytes: Involvement of P2X7 receptor

Immunobiology

Volumn 218, Issue 4, 2013, Pages 591-601

  Sakowicz Burkiewicz, Monika ^a   Kocbuch, Katarzyna ^a   Grden, Marzena ^a   Maciejewska, Izabela ^a   Szutowicz, Andrzej ^a   Pawelczyk, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

ATP; B lymphocytes; Glucose; IgM; IL 2; P2X7

Indexed keywords

ADENOSINE TRIPHOSPHATE; BACTERIAL ANTIGEN; GLUCOSE; IMMUNOGLOBULIN M; INTERLEUKIN 2; PURINERGIC P2X7 RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; B LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATE; ANTIBODY FORMATION; B-LYMPHOCYTES; CELLS, CULTURED; DIABETES COMPLICATIONS; FEMALE; GLUCOSE; HUMANS; HYPERGLYCEMIA; IMMUNITY, HUMORAL; IMMUNOGLOBULIN M; INFECTION; MALE; PURINERGIC P2X RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2X7; STAPHYLOCOCCUS AUREUS; THIAZOLES;

EID: 84875239634     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.07.010     Document Type: Article

References (40)

1. Adinolfi E., Callegari M.G., Ferrari D., Bolognesi C., Minelli M., Wieckowski M.R., Pinton P., Rizzuto R., Di Virgilio F. Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. Mol. Biol. Cell 2005, 16(7):3260-3272.
2. Alexiewicz J.M., Kumar D., Smogorzewski M., Klin M., Massry S.G. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function. Ann. Intern. Med. 1995, 123(12):919-924.
3. Baricordi O.R., Melchiorri L., Adinolfi E., Falzoni S., Chiozzi P., Buell G., Di Virgilio F. Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor. J. Biol. Chem. 1999, 274(47):3332-33208.
4. Benfield T., Jensen J.S., Nordesgaard B.G. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 2007, 50(3):549-554.
5. Bours M.J., Swennen E.L., Virgilio F., Cronstein B.N., Dagnelie P.C. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 2006, 112(2):358-404.
6. Boyko E.J., Fihn S.D., Scholes D., Abraham L., Monsey B. Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women. Am. J. Epidemiol. 2005, 161(6):557-564.
7. Chang F.Y., Shaio M.F. Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 1995, 28(2):137-146.
8. Coddou C., Yan Z., Obsil T., Huidobro-Toro J.P., Stojilkovic S.S. Activation and regulation of purinergic P2X receptor channels. Pharmacol. Rev. 2011, 63(3):641-683.
9. Edwards M.S., Fuselier P.A. Enhanced susceptibility of mice with streptozotocin-induced diabetes to type II group B streptococcal infection. Infect. Immun. 1983, 39(2):580-585.
10. Eibl N., Spatz M., Fischer G.F., Mayr W.R., Samstag A., Wolf H.M., Schernthaner G., Eibl M.M. Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study. Clin. Immunol. 2002, 103(3 (Pt 1)):249-259.
11. Evans R.J., Lewis C., Buell G., Valera S., North R.A., Surprenant A. Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2X purinoceptors). Mol. Pharmacol. 1995, 48(2):178-183.
12. Gabel C.A. P2 purinergic receptor modulation of cytokine production. Purinergic Signal 2007, 3(1-2):27-28.
13. Glassman A.B., Lindsay J.H., Levine J.H., Bennett C.E. T and B lymphocyte subpopulations in black patients with diabetes mellitus. Ann. Clin. Lab. Sci. 1978, 8(6):467-471.
14. Humphreys B.D., Dubyak G.R. Induction of the P2Z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and INF-gamma in the human THP-1 monocytic cell line. J. Immunol. 1996, 157(12):5627-5637.
15. Jagannathan M., McDonnell M., Liang Y., Hasturk H., Hetzel J., Rubin D., Kantarci A., Van Dyke T.E., Ganley-Leal L.M., Nikolajczyk B.S. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 2010, 53(7):1461-1471.
16. Joseph S.M., Buchakjian M.R., Dubyak G.R. Colocalization of ATP release sites and ecto-ATPase activity at the extracellular surface of human astrocytes. J. Biol. Chem. 2003, 278(26):23331-23342.
17. Kocbuch K., Sakowicz-Burkiewicz M., Grden M., Szutowicz A., Pawelczyk T. Effect of insulin and glucose on adenosine metabolizing enzymes in human B lymphocytes. Acta Biochim. Pol. 2009, 56(3):439-446.
18. Kornum J.B., Thomsen R.W., Riis A., Lervang H.H., Schonheyder H.C., Sorensen H.T. Type 2 diabetes and pneumonia outcomes: a population-based cohort study. Diabetes Care 2007, 30(9):2251-2257.
19. Koziel H., Koziel M.J. Pulmonary complications of diabetes mellitus: pneumonia. Infect. Dis. Clin. North Am. 1995, 9(1):65-96.
20. Lambrecht G., Rettinger J., Baumert H.G., Czeche S., Damer S., Ganso M., Hildebrandt C., Niebel B., Spatz-Kumbel G., Schmalzing G., Mutschler E. The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X(1) receptors. Eur. J. Pharmacol. 2000, 387(3):R19-R21.
21. Lazarowski E.R., Homolya L., Boucher R.C., Harden T.K. Direct demonstration of mechanically induced release of cellular UTP and its implication for uridine nucleotide receptor activation. J. Biol. Chem. 1997, 272(39):24348-24354.
22. Liberatore R.R., Barbosa S.F., Alkimin M.G., Bellinati-Pires R., Florido M.P., Isaac L., Kirschfink M., Grumach A.S. Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus. Pediatr. Diabetes 2005, 6(4):206-212.
23. Narcisse L.E., Scemes Y., Zhao S.C., Brosnan C.F. The cytokine IL-1β transiently enhances P2X7 receptor expression and function in human astrocytes. Glia 2005, 49(2):245-258.
24. Pawelczyk T., Sakowicz M., Podgorska M., Szczepanska-Konkel M. Insulin induces expression of adenosine kinase gene in rat lymphocytes by signaling through the mitogen-activated protein kinase pathway. Exp. Cell Res. 2003, 286(1):152-163.
25. Pawelczyk T., Sakowicz-Burkiewicz M., Kocbuch K., Szutowicz A. Differential effect of insulin and elevated glucose level on adenosine handling in rat T lymphocytes. J. Cell. Biochem. 2005, 96(6):1296-1310.
26. Qu Y., Dubyak G.R. P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways. Purinergic Signal 2009, 5(5):163-173.
27. Ramagnoli R., Baraldi P.G., Cruz-Lopez O., Lopez-Cara C., Preti D., Borea P.A., Gessi S. The P2X7 receptor as a therapeutic target. Expert Opin. Ther. Targets 2008, 12:647-661.
28. Rubinstein R., Genaro A.M., Motta A., Cremaschi G., Wald M.R. Impaired immune responses in streptozotocin-induced type I diabetes in mice. Involvement of high glucose. Clin. Exp. Immunol. 2008, 154(2):235-246.
29. Rucker B., Abreu-Vieira G., Bischoff L.B., Hartmann A.D., Sarkis J.J., Wink M.R., Casali E.A. The nucleotide hydrolysis is altered in blood serum of streptozotocin-induced diabetic rats. Arch. Physiol. Biochem. 2010, 116(2):79-87.
30. Sakowicz-Burkiewicz M., Kocbuch K., Grden M., Szutowicz A., Pawelczyk T. Adenosine 5'-triphosphate is the predominant source of peripheral adenosine in human B lymphoblasts. J. Physiol. Pharmacol. 2010, 61(4):491-499.
31. Sakowicz-Burkiewicz M., Kocbuch K., Grden M., Szutowicz A., Pawelczyk T. Diabetes-induced decrease of adenosine kinase expression impairs the proliferation potential of diabetic rat T lymphocytes. Immunology 2006, 118(3):402-412.
32. Sakowicz-Burkiewicz M., Pawelczyk T. Recent advances in understanding the relationship between adenosine metabolism and the function of T and B lymphocytes in diabetes. J. Physiol. Pharmacol. 2011, 62(5):505-512.
33. Schloot N.C., Roep B.O., Wegmann D., Yu L., Chase H.P., Wang T., Eisenbarth G.S. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia 1997, 40(5):564-572.
34. Schuetz P., Castro P., Shapiro N.I. Diabetes and sepsis: preclinical findings and clinical relevance. Diabetes Care 2001, 34(3):771-778.
35. Shah B.R., Hux J.E. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003, 26(2):510-513.
36. Shi Y., Agematsu K., Ochs H.D., Sugane K. Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM. Clin. Immunol. 2003, 108(2):128-137.
37. Sluyter R., Barden J.A., Wiley J.S. Detection of P2X purinergic receptors on human B lymphocytes. Cell Tissue Res. 2001, 304(2):231-236.
38. Takeda Y., Wakabayashi I. Alteration in lymphocyte population and humoral immune response in type 2 diabetic Goto-Kakizaki rats. Life Sci. 2012, 90(13-14):545-552.
39. Warnatz K., Denz A., Drager R., Braun M., Groth C., Wolff-Vorbeck G., Eibel H., Schlesier M., Peter H.H. Severe deficiency of switched memory B cells (CD27(+) IgM(-) IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002, 99(5):1544-1551.
40. Watt W.C., Lazarowski E.R., Boucher R.C. Cystic fibrosis transmembrane regulator-independent release of ATP. Its implications for the regulation of P2Y2 receptors in airway epithelia. J. Biol. Chem. 1998, 273(22):14053-14058.